Activity 9: Transforming the current infrastructure for combating HBV and HCV infections

Journal of Family Practice

Volumn 59, Issue SUPPL. 4, 2010, Pages

  Kim, W Ray ^a   Ward, John W ^b   Cheever, Laura W ^c   Dan, Corinna ^d   Dee, Lynda ^e   Zola, Janet ^f  

^a Mayo Clinic   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

^d Association of Asian Pacific Community Health Organizations   (United States)

^e Maryland Hepatitis Coalition   (United States)

^f SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT VACCINE;

CLINICAL RESEARCH; CONFERENCE PAPER; COOPERATION; DECOMPENSATED LIVER CIRRHOSIS; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; LIVER CELL CARCINOMA; MASS IMMUNIZATION; MEDICAID; MEDICARE; MIXED INFECTION; MORBIDITY; PATIENT EDUCATION; PATIENT SAFETY; PRIMARY HEALTH CARE; PUBLIC HEALTH SERVICE; VIRUS TRANSMISSION; ARTICLE; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; UNITED STATES;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; NATIONAL HEALTH PROGRAMS; PREVENTIVE HEALTH SERVICES; UNITED STATES;

EID: 77951276775     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. NASTAD (National Alliance of State and Territorial AIDS Directors). HIV and hepatitis co-infection unmet need. October 14, 2008. www.nastad.org/Docs/ Public/Resource/20081014-FY2009%20Viral%20Hepatitis%20and%20HIV%20Co-Infection. pdf. Accessed January 22, 2010.
2. Ward J. Modernizing the CDC's public health approach to the control of chronic viral hepatitis B and C. Presented at: The Dawn of a New Era: Transforming Our Domestic Response to Hepatitis B & C; September 10-11, 2009; Washington, DC.
3. Centers for Disease Control and Prevention. Viral hepatitis. www.cdc.gov/hepatitis. Accessed December 16, 2009.
4. Pyenson B, Fitch K, Iwasaki K. Consequences of hepatitis C virus (HCV): costs of a baby boomer epidemic of liver disease. www.milliman.com/expertise/ healthcare/publications/rr/consequences-hepatits-c-virus-RR05-15-09.php. Accessed December 11, 2009.
5. Centers for Disease Control and Prevention. Racial and ethnic approaches to community health: risk factor survey. www.cdc.gov/reach/risk-factor-survey. htm. Accessed December 11, 2009.
6. Centers for Disease Control and Prevention. Racial and ethnic approaches to community health: about REACH across the US (2007 to present). www.cdc.gov/reach/about.htm. Accessed December 11, 2009.
7. Centers for Disease Control and Prevention. Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors - United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005. MMWR. 2006;55(SS-6):1-16.
8. Colvin H, Mitchell A. Institute of Medicine of the National Academies. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Washington, DC: National Academic Press; 2010.
9. Centers for Disease Control and Prevention. Viral hepatitis-funded partners. Updated October 29, 2009. www.cdc.gov/hepatitis/Partners/Adult/ AdultHepCoordsList.htm. Accessed December 16, 2009.
10. Centers for Disease Control and Prevention. Hepatitis B. In: Manual for the surveillance of vaccine-preventable diseases. 4th ed. 2008; chap 4. www.cdc.gov/vaccines/pubs/surv-manual. Accessed December 16, 2009.
11. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;29:328-333.
12. Thompson ND, Perz JF, Moorman AC, et al. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med. 2009;150:33-39.
13. Centers for Disease Control and Prevention. Hepatitis B FAQs for health professionals. www.cdc.gov/hepatitis/HBV/HBVfaq.htm. Accessed December 11, 2009.
14. Cheever L. Creating a health care safety net for hepatitis C in Ryan White Programs. Presented at: The Dawn of a New Era: Transforming Our Domestic Response to Hepatitis B & C; September 10-11, 2009; Washington, DC.
15. Sherman KE, Rouster SD, Chung RT, et al. Hepatitis C Virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34:831-837.
16. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med. 2003;138:197-207.
17. Palella FJ, Jr., Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27-34.
18. Marin B TR, Rondeau V, et al. Association between CD4 and HIV RNA with non-AIDS-related causes of death in the era of combination antiretroviral therapy (cART). CASCADE Study Group. Presented at: 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; July 22-25, 2007; Sydney, Australia.
19. NASTAD (National Alliance of State and Territorial AIDS Directors). National ADAP Monitoring Project annual report. April 2009. www.nastad.org/Docs/ highlight/200946-7861%20FULL%20REPORT%20v3.pdf. Accessed December 11, 2009.